サマリー

内分泌系薬剤の世界市場 2023-2027
Technavioは内分泌学薬品市場を監視しており、2023年から2027年にかけて3651.24万ドルの成長が見込まれ、予測期間中にCAGR 7.82%で加速しています。当レポートでは、内分泌系医薬品市場の全体分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。内分泌疾患の発生率の増加、内分泌学の有望なパイプライン、新規製剤や薬物送達システムの研究などが市場を牽引しています。
Technavioの内分泌系医薬品市場は以下のようにセグメント化されています。
治療領域別
- 糖尿病治療薬
- HGH
- 甲状腺ホルモン障害
- その他
販売チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、肥満と内分泌疾患との関連が、今後数年間の内分泌疾患治療薬市場の成長を促進する主要な理由の1つであると位置づけています。また、内分泌疾患に対するバイオシミラーの使用と老年人口の増加が、市場の大きな需要につながると考えられます。
Technavioは、主要パラメータの分析を通じて、複数のソースからのデータの調査、合成、総括を行い、市場の詳細な姿を提示します。内分泌系医薬品市場に関する当レポートの対象領域は以下の通りです。
- 内分泌系薬剤の市場サイジング
- 内分泌系疾患治療薬市場の予測
- 内分泌系医薬品市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Abbott Laboratories、Acerus Pharmaceuticals Corp、Ascendis Pharma AS、Bayer AG、Beta Cell NV、Biocon Ltd、Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc、Hanmi Pharm Co.Ltd.、Ipsen Pharma、Merck and Co.Inc.、ノバルティスAG、ノボ ノルディスクAS、オーラメッド社、ファイザー社、サノフィSA、武田薬品工業社、ヴェロスクライン社などです。Ltd.、武田薬品工業株式会社、VeroScience LLCの7社が含まれています。また、内分泌製剤市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/endocrinology-drugs-market-industry-analysis をご覧ください。
Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数のソースからのデータの調査、合成、総括を行い、市場の詳細な姿を提示します。業界の主要な影響力を持つ人物を特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy Area
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global endocrinology drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global endocrinology drugs market 2017 - 2021 ($ million)
o 4.2 Therapy Area Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Therapy Area Segment 2017 - 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Therapy Area
o 6.1 Market segments
o Exhibit 30: Chart on Therapy Area - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapy Area - Market share 2022-2027 (%)
o 6.2 Comparison by Therapy Area
o Exhibit 32: Chart on Comparison by Therapy Area
o Exhibit 33: Data Table on Comparison by Therapy Area
o 6.3 Diabetes drugs - Market size and forecast 2022-2027
o Exhibit 34: Chart on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Diabetes drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Diabetes drugs - Year-over-year growth 2022-2027 (%)
o 6.4 hGH - Market size and forecast 2022-2027
o Exhibit 38: Chart on hGH - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on hGH - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on hGH - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on hGH - Year-over-year growth 2022-2027 (%)
o 6.5 Thyroid hormone disorders - Market size and forecast 2022-2027
o Exhibit 42: Chart on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
o 6.6 Others - Market size and forecast 2022-2027
o Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Therapy Area
o Exhibit 50: Market opportunity by Therapy Area ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 51: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 52: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 53: Chart on Comparison by Distribution Channel
o Exhibit 54: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacies - Market size and forecast 2022-2027
o Exhibit 55: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o 7.4 Retail pharmacies - Market size and forecast 2022-2027
o Exhibit 59: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacies - Market size and forecast 2022-2027
o Exhibit 63: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 67: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 71: Chart on Geographic comparison
o Exhibit 72: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Acerus Pharmaceuticals Corp.
o Exhibit 116: Acerus Pharmaceuticals Corp. - Overview
o Exhibit 117: Acerus Pharmaceuticals Corp. - Product / Service
o Exhibit 118: Acerus Pharmaceuticals Corp. - Key offerings
o 12.4 Bayer AG
o Exhibit 119: Bayer AG - Overview
o Exhibit 120: Bayer AG - Business segments
o Exhibit 121: Bayer AG - Key offerings
o Exhibit 122: Bayer AG - Segment focus
o 12.5 Beta Cell NV
o Exhibit 123: Beta Cell NV - Overview
o Exhibit 124: Beta Cell NV - Product / Service
o Exhibit 125: Beta Cell NV - Key offerings
o 12.6 Eli Lilly and Co.
o Exhibit 126: Eli Lilly and Co. - Overview
o Exhibit 127: Eli Lilly and Co. - Product / Service
o Exhibit 128: Eli Lilly and Co. - Key offerings
o 12.7 Endo International Plc
o Exhibit 129: Endo International Plc - Overview
o Exhibit 130: Endo International Plc - Business segments
o Exhibit 131: Endo International Plc - Key news
o Exhibit 132: Endo International Plc - Key offerings
o Exhibit 133: Endo International Plc - Segment focus
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 GlaxoSmithKline Plc
o Exhibit 139: GlaxoSmithKline Plc - Overview
o Exhibit 140: GlaxoSmithKline Plc - Business segments
o Exhibit 141: GlaxoSmithKline Plc - Key offerings
o Exhibit 142: GlaxoSmithKline Plc - Segment focus
o 12.10 Hanmi Pharm Co. Ltd.
o Exhibit 143: Hanmi Pharm Co. Ltd. - Overview
o Exhibit 144: Hanmi Pharm Co. Ltd. - Product / Service
o Exhibit 145: Hanmi Pharm Co. Ltd. - Key offerings
o 12.11 Ipsen Pharma
o Exhibit 146: Ipsen Pharma - Overview
o Exhibit 147: Ipsen Pharma - Business segments
o Exhibit 148: Ipsen Pharma - Key offerings
o Exhibit 149: Ipsen Pharma - Segment focus
o 12.12 Merck and Co. Inc.
o Exhibit 150: Merck and Co. Inc. - Overview
o Exhibit 151: Merck and Co. Inc. - Business segments
o Exhibit 152: Merck and Co. Inc. - Key news
o Exhibit 153: Merck and Co. Inc. - Key offerings
o Exhibit 154: Merck and Co. Inc. - Segment focus
o 12.13 Novartis AG
o Exhibit 155: Novartis AG - Overview
o Exhibit 156: Novartis AG - Business segments
o Exhibit 157: Novartis AG - Key offerings
o Exhibit 158: Novartis AG - Segment focus
o 12.14 Novo Nordisk AS
o Exhibit 159: Novo Nordisk AS - Overview
o Exhibit 160: Novo Nordisk AS - Business segments
o Exhibit 161: Novo Nordisk AS - Key offerings
o Exhibit 162: Novo Nordisk AS - Segment focus
o 12.15 Pfizer Inc.
o Exhibit 163: Pfizer Inc. - Overview
o Exhibit 164: Pfizer Inc. - Product / Service
o Exhibit 165: Pfizer Inc. - Key news
o Exhibit 166: Pfizer Inc. - Key offerings
o 12.16 Sanofi SA
o Exhibit 167: Sanofi SA - Overview
o Exhibit 168: Sanofi SA - Business segments
o Exhibit 169: Sanofi SA - Key news
o Exhibit 170: Sanofi SA - Key offerings
o Exhibit 171: Sanofi SA - Segment focus
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 176: Inclusions checklist
o Exhibit 177: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 178: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 179: Research methodology
o Exhibit 180: Validation techniques employed for market sizing
o Exhibit 181: Information sources
o 13.5 List of abbreviations
o Exhibit 182: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global endocrinology drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Area Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy Area - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy Area - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy Area
Exhibits33: Data Table on Comparison by Therapy Area
Exhibits34: Chart on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Diabetes drugs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Diabetes drugs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on hGH - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on hGH - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on hGH - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on hGH - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Therapy Area ($ million)
Exhibits51: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits52: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by Distribution Channel
Exhibits54: Data Table on Comparison by Distribution Channel
Exhibits55: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Distribution Channel ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Acerus Pharmaceuticals Corp. - Overview
Exhibits117: Acerus Pharmaceuticals Corp. - Product / Service
Exhibits118: Acerus Pharmaceuticals Corp. - Key offerings
Exhibits119: Bayer AG - Overview
Exhibits120: Bayer AG - Business segments
Exhibits121: Bayer AG - Key offerings
Exhibits122: Bayer AG - Segment focus
Exhibits123: Beta Cell NV - Overview
Exhibits124: Beta Cell NV - Product / Service
Exhibits125: Beta Cell NV - Key offerings
Exhibits126: Eli Lilly and Co. - Overview
Exhibits127: Eli Lilly and Co. - Product / Service
Exhibits128: Eli Lilly and Co. - Key offerings
Exhibits129: Endo International Plc - Overview
Exhibits130: Endo International Plc - Business segments
Exhibits131: Endo International Plc - Key news
Exhibits132: Endo International Plc - Key offerings
Exhibits133: Endo International Plc - Segment focus
Exhibits134: F. Hoffmann La Roche Ltd. - Overview
Exhibits135: F. Hoffmann La Roche Ltd. - Business segments
Exhibits136: F. Hoffmann La Roche Ltd. - Key news
Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits139: GlaxoSmithKline Plc - Overview
Exhibits140: GlaxoSmithKline Plc - Business segments
Exhibits141: GlaxoSmithKline Plc - Key offerings
Exhibits142: GlaxoSmithKline Plc - Segment focus
Exhibits143: Hanmi Pharm Co. Ltd. - Overview
Exhibits144: Hanmi Pharm Co. Ltd. - Product / Service
Exhibits145: Hanmi Pharm Co. Ltd. - Key offerings
Exhibits146: Ipsen Pharma - Overview
Exhibits147: Ipsen Pharma - Business segments
Exhibits148: Ipsen Pharma - Key offerings
Exhibits149: Ipsen Pharma - Segment focus
Exhibits150: Merck and Co. Inc. - Overview
Exhibits151: Merck and Co. Inc. - Business segments
Exhibits152: Merck and Co. Inc. - Key news
Exhibits153: Merck and Co. Inc. - Key offerings
Exhibits154: Merck and Co. Inc. - Segment focus
Exhibits155: Novartis AG - Overview
Exhibits156: Novartis AG - Business segments
Exhibits157: Novartis AG - Key offerings
Exhibits158: Novartis AG - Segment focus
Exhibits159: Novo Nordisk AS - Overview
Exhibits160: Novo Nordisk AS - Business segments
Exhibits161: Novo Nordisk AS - Key offerings
Exhibits162: Novo Nordisk AS - Segment focus
Exhibits163: Pfizer Inc. - Overview
Exhibits164: Pfizer Inc. - Product / Service
Exhibits165: Pfizer Inc. - Key news
Exhibits166: Pfizer Inc. - Key offerings
Exhibits167: Sanofi SA - Overview
Exhibits168: Sanofi SA - Business segments
Exhibits169: Sanofi SA - Key news
Exhibits170: Sanofi SA - Key offerings
Exhibits171: Sanofi SA - Segment focus
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits175: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Validation techniques employed for market sizing
Exhibits181: Information sources
Exhibits182: List of abbreviations